214 related articles for article (PubMed ID: 25998946)
1. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.
Kaliki S; Ayyar A; Dave TV; Ali MJ; Mishra DK; Naik MN
Eye (Lond); 2015 Jul; 29(7):958-63. PubMed ID: 25998946
[TBL] [Abstract][Full Text] [Related]
2. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management.
Lam SC; Li EYM; Yuen HKL
Br J Ophthalmol; 2018 Dec; 102(12):1723-1727. PubMed ID: 29459429
[TBL] [Abstract][Full Text] [Related]
3. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
[TBL] [Abstract][Full Text] [Related]
4. Patterns of lymphatic spread and the management of eyelid carcinomas.
Hashimoto K; Yasumatsu R; Toh S; Shiratsuchi H; Yoshida T; Nishiyama K; Yoshikawa H; Nakashima T; Nakagawa T
Auris Nasus Larynx; 2016 Dec; 43(6):666-71. PubMed ID: 26965587
[TBL] [Abstract][Full Text] [Related]
5. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
6. Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid - a population-based analysis.
Lee IJ; Koh JY
Orbit; 2019 Aug; 38(4):261-268. PubMed ID: 30373440
[No Abstract] [Full Text] [Related]
7. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
Kaliki S; Gupta A; Ali MH; Ayyar A; Naik MN
Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
[TBL] [Abstract][Full Text] [Related]
8. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Systemic Chemotherapy in the Management of Extensive Eyelid Sebaceous Gland Carcinoma: A study of 10 Cases.
Kaliki S; Ayyar A; Nair AG; Mishra DK; Reddy VA; Naik MN
Ophthalmic Plast Reconstr Surg; 2016; 32(1):35-9. PubMed ID: 25675161
[TBL] [Abstract][Full Text] [Related]
10. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.
Husain A; Blumenschein G; Esmaeli B
Int J Dermatol; 2008 Mar; 47(3):276-9. PubMed ID: 18289332
[TBL] [Abstract][Full Text] [Related]
11. Sebaceous carcinoma of the eyelid: a clinicopathological study.
Zürcher M; Hintschich CR; Garner A; Bunce C; Collin JR
Br J Ophthalmol; 1998 Sep; 82(9):1049-55. PubMed ID: 9893597
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
[TBL] [Abstract][Full Text] [Related]
13. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.
Esmaeli B; Nasser QJ; Cruz H; Fellman M; Warneke CL; Ivan D
Ophthalmology; 2012 May; 119(5):1078-82. PubMed ID: 22330966
[TBL] [Abstract][Full Text] [Related]
14. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
Kan LW; Leu YS; Tzen CY; Wu CH
Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
[TBL] [Abstract][Full Text] [Related]
15. Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y; Yeh CY; Wei YH; Chen LW; Liao SL
Eye (Lond); 2019 Jun; 33(6):887-895. PubMed ID: 31147618
[TBL] [Abstract][Full Text] [Related]
16. Sebaceous carcinoma of the eyelid: a review of 14 cases.
Callahan EF; Appert DL; Roenigk RK; Bartley GB
Dermatol Surg; 2004 Aug; 30(8):1164-8. PubMed ID: 15274713
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.
Choi YJ; Jin HC; Lee MJ; Kim N; Choung HK; Khwarg SI
Jpn J Ophthalmol; 2014 Jul; 58(4):327-33. PubMed ID: 24763914
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Local Recurrence or Metastasis of Eyelid Sebaceous Gland Carcinoma After Wide Excision With Paraffin Section Control.
Takahashi Y; Takahashi E; Nakakura S; Kitaguchi Y; Mupas-Uy J; Kakizaki H
Am J Ophthalmol; 2016 Nov; 171():67-74. PubMed ID: 27590119
[TBL] [Abstract][Full Text] [Related]
19. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]